The Nuclear Boom Is Real. These 3 Stocks Are the Smartest Long-Term Buys.

The article argues that nuclear demand is accelerating, with Cameco estimating uranium supply could be outstripped in the 2030s as 72 reactors are under construction and older units are being restarted or extended. It highlights Cameco and Brookfield Renewable as more conservative picks, while NuScale and Oklo are described as higher-risk, higher-reward small modular reactor plays. Brookfield’s 4.5% yield and Cameco’s 300% gain over three years are noted as key differentiators for investors.

Analysis

The market is likely underestimating how much of the nuclear trade is really a fuel-cycle trade, not a reactor-construction trade. In the near-to-medium term, the cleanest beneficiary is the uranium/refueling ecosystem because new build timelines are long, while restart, life-extension, and capacity-factor optimization can tighten spot demand much faster; that means pricing power can show up in cash flows before most of the “new reactor” narrative is reflected in earnings. The second-order winner is service and maintenance capacity tied to existing fleet uptime, which tends to compound with every incremental year a plant stays online.

The embedded asymmetry is that the risky developers are trading on technology optionality while the commercial payoffs sit years away and require regulatory, financing, and execution milestones to line up. If small modular reactors do not achieve cost-down plus standardization, the equity value of OKLO/SMR can re-rate sharply lower because the market is currently paying for a large addressable market with little realized revenue. Even in a successful scenario, long-cycle infrastructure economics suggest dilution and project-finance dependency will remain a major overhang for several years.

Brookfield’s angle is more interesting than a simple yield play: the Westinghouse stake gives it a toll-road claim on the industry without requiring a binary bet on one reactor design. That said, the stock may be partially de-risking a nuclear premium already, so upside likely comes from evidence of higher backlog quality and maintenance/service revenue, not headline reactor announcements. The contrarian miss is that the trade is not just about power demand growth; it is also about the scarcity of qualified nuclear supply-chain capacity, which can lift margins for the few incumbents with licensing, engineering, and fuel access.

Key Decisions for Investors

• Long CCJ on a 3-9 month horizon as the highest-conviction way to express tightening uranium/fuel-cycle supply; use pullbacks to add, with a risk/reward favoring continued multiple support if spot pricing stays firm.
• Long BEP vs short a basket of high-duration SMR developers (e.g., paired against OKLO/SMR) for a lower-volatility way to own the nuclear renaissance while hedging execution risk; target 6-12 months.
• Avoid initiating fresh long exposure in OKLO/SMR at current levels unless as a small call-option-sized position; the asymmetry is poor if commercialization slips by even 12-24 months.
• If options liquidity allows, consider a CCJ call spread or BEP call spread into the next catalyst window rather than outright stock, to capture upside while limiting headline-driven volatility.
• Watch for any evidence of reactor restart/life-extension announcements; those are the fastest fundamental catalysts for the supply chain and can move CCJ/BEP faster than new-build headlines.